Stay informed with the latest updates for the inheritable blood disorders community. IndustryREGENX/Chatham to Develop Genetically Based Hemophilia TherapiesApr 1, 2012 IndustryCSL Announces Site for Longer-Acting Recombinant FIX StudyFeb 1, 2012 IndustryAMT's Hemophilia B Gene Therapy Program Granted Orphan Drug StatusFeb 1, 2012 IndustryCatalyst Initiates Phase I Trial for rVIIa Product for InhibitorsFeb 1, 2012 IndustryAchillion's HCV Drug Receives Fast Track DesignationFeb 1, 2012 IndustryBaxter Announces Approval of ADVATE for Prophylaxis and Longer-…Jan 1, 2012 IndustryFDA Approves Pfizer's BeneFIX 3,000 IU DosageDec 1, 2011 IndustryBaxter's Recombinant VWF Product Starting Phase 3 Clinical TrialNov 1, 2011 IndustryBayer Standardizes Syringe for KogenateFS Vial SizesNov 1, 2011 IndustryPfizer Announces Improvements to XYNTHA and BeneFIXSep 1, 2011 IndustryBiogen Idec and Swedish Orphan Biovitrum Report Clinical ProgressAug 1, 2011 IndustryInspiration Presents Data on Recombinant FVIII ProductAug 1, 2011 IndustryBayer HealthCare Announces 2011 BHAP WinnersAug 1, 2011 IndustryBaxter Reports Progress on Hemophilia and Recombinant VWF TreatmentsAug 1, 2011 IndustryFTC Approves Grifols-Talecris Merger, Kedrion Acquisition of Koate-DVIJul 1, 2011 Pagination First page Previous page … Page 16 Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Page 23 Page 24 Next page Last page
